Hochhaus G., Gonzalez M.A., Shilstone J., Karafilidis J. “A New
Solution Based Intranasal Triamcinolone Acetonide Formulation In Patients
With Perennial Allergic Rhinitis: How Does The PK/PD Profile For Cortisol
Suppression Compare With An Aqueous Suspension Based Formulation?”
Journal of Clinical Pharmacology, 42:662-669 (2002).
Mobley C., Hochhaus G. “Pharmacokinetic Considerations in the
Design of Pulmonary Drug Delivery Systems for Glucocorticoids.” In:
H. Schreier (ed.), Drug Targeting Technology, Marcel Dekker, New York,
51-83 (2001).
Krishnaswami S., Möllmann H., Derendorf H., Hochhaus G. “Sensitive
LC-MS/MS Method for the Quantification of Fluticasone Propionate in Human
Plasma.” Journal of Pharm. Biomed. Analysis, 22:123-129 (2000).
Talton J., Fitz-Gerald J., Singh R., Hochhaus G. “Nano-thin Coatings
for Improved Lung Targeting of Glucocorticoid Dry Powders: In-vitro and
In-vivo Characteristics.” Respiratory Drug Delivery VII, R. Dalby, P. Byron,
S.J. Farr, eds, Interpharm Press, Buffalo Grove, IL, 67-74 (2000).
Müller S., Hutson A., Arya V., Hochhaus G. “Assessment of
Complex Peptide Degradation Pathways Via Structured Multi-compartmental
Modeling Approaches: The Metabolism of Dynorphin A1-13 and Related Fragments
in Human Plasma.” Journal of Pharm. Science, 88:938-944 (1999).